It was suggested that AZGP1 is part of a mechanism by which growth hormone (GH) modulates subcutaneous adipose tissue lipid metabolism indicating a potential role for GH-AZGP1 axis in protecting against the development of obesity [53]. The gene discussed is GH1; the disease is obesity due to melanocortin 4 receptor deficiency.